shopping cart Your cart is empty
  • Home
  • Medical Devices
  • ENT (Ear, Nose And Throat) Devices Market Analysis By Devices (Hearing Aid Devices, Hearing Implants, Diagnostic, Nasal Splints, V...

ENT (Ear, Nose And Throat) Devices Market Analysis By Devices (Hearing Aid Devices, Hearing Implants, Diagnostic, Nasal Splints, Voice Prosthesis & Surgical Devices), By End User Application (Volume Share By Region, North America, Asia Pacific, Middle East & Africa & Central & South America), Industry Size, Growth, Share And Forecast To 2022

Published By: Brisk Insights | Published On: Jan 22, 2016

Key findings


The global ENT (Ear, Nose, and Throat) is expected to grow at a CAGR of 6.8% during 2015-2022 and is estimated to be approximately $14.3 billion at the end of the forecasted period i.e. by 2022. The global ENT devices market is driven by many factors such as growing adoption across several sectors such as home use, hospitals, Ambulatory settings and ENT clinics.

 

Some of the other reasons for the growth of the market are increasing trend of customized implants, advancement of technologies, increasing incidents of sinusitis and geriatric population base. Ageing population is continuously increasing and due to this the market of ENT device is also witnessing exponential growth. As per the action of hearing loss information more than 10 million people in UK suffer from hearing loss and in this 6.4 million belong to the age group of 65 and above. Due to excellent growth of the market many new members are entering in to the field which is again turning out to be a strong driver for the market. There exist many opportunities in the ENT device industry market which must be utilized to obtain the best possible result some of them are emerging economies worldwide, government support to enhance healthcare services and increasing demand for cosmetic ENT procedures.

 

Some of the restraints faced by the industry are prevalence of social stigmas and High cost of procedures and instruments. Lack of proper reimbursements facility for hearing aids is one of the major issues in the industry which is required to be solved soon.


Market segment insight


The application market for ENT devices market is segmented as follows: Based on devices such as Hearing aid devices market, Hearing Implants market, Diagnostic devices market, Nasal splints market, Voice prosthetics market, surgical device market and lastly on the basis of end user application. During the year 2015 endoscopes segmented had the largest market share of all the other diagnostic devices present in the market and it is expected that this segment would be maintaining its dominance in the diagnostic devices industries. Among the surgical devices market handheld instruments is having the largest market share and the segment is expected to maintain its growth and remain on the top in the upcoming year.


Regional insight


North America hold the largest market share among the other regions followed by Europe. It is estimated that North America and Europe together have 60% of the total market share followed by Asia Pacific. Asia Pacific is expected to grow with the fastest CAGR of approx. 6.9%.


Competitive insight


The Key Players in the ENT device industry include Medtronic Plc, Olympus Corporation, Stryker Corporation, and Hoya Corporation, Sonova holdings AG, Cochlear limited and William Demant holdings. Innovation is the key strategy adopted in the ENT device industry. Increase in the number of market players and adoption of more advanced methods as compared to the conventional ones are the key market trend of the industry.


Reasons for buying the report

 

  • This report provides a detailed study of current trends in the ENT devices market, key growth drivers, and restraints.
  • It provides market forecast for the next 7 years (2015-2022) assessed on the basis of market growth.
  • The report also includes analysis of recent technological developments in the ENT devices market, analysis of key market players and the key winning strategy adopted and predictive analysis.
  • The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.
  • The report tracks and analyse the changing market dynamics.
  • The report also talks about emerging opportunities in the market and the future impact of major drivers and restraints of the market.
  • The report also provides extensive analysis with respect to key product segments.
    The analysis in the report will help in making effective business decisions.

1. METHODOLOGY & SCOPE 13


    1.1. RESEARCH METHODOLOGY 13
    1.2. RESEARCH SCOPE & ASSUMPTIONS 13
    1.3. LIST OF DATA SOURCES 13


2. EXECUTIVE SUMMARY 13


    2.1. GLOBAL ENT DEVICES– INDUSTRY SUMMARY & KEY BUYING CRITERIA 13
    2.2. GLOBAL ENT DEVICES INDUSTRY OUTLOOK 13


3. MARKET SEGMENTATION 13


    3.1. MARKET SIZE AND GROWTH PROSPECTS 2012-2022 13
    3.2. ENT DEVICES INDUSTRY VALUE CHAIN ANALYSIS 13
    3.3. VENDOR LANDSCAPE 13


4. GLOBAL ENT MARKET DYNAMICS 13


    4.1. MARKET DRIVER ANALYSIS 13
        4.1.1 INCREASING TREND OF CUSTOMIZED IMPLANTS 13
        4.1.2 ADVANCEMENT IN TECHNOLOGY LEADING TO GROWTH IN APPLICATION 13
        4.1.3 INCREASING INCIDENCE OF SINUSITIS 13
        4.1.4 INCREASING GERIATIC POPULATION BASE 13
        4.1.5 INCREASING MARKET PLAYERS 13
    4.2. MARKET RESTRAINT ANALYSIS 13
        4.2.1 SOCIAL STIGMAS PREVALENCE 13
        4.2.2 HIGH COST OF PROCEDURES AND INSTRUMENTS 13
        4.2.3 LACK OF PROPER REIMBURSEMENT POLICIES 13
    4.3. KEY OPPORTUNITIES 13
        4.3.1 INCREASING DEMAND FOR COSMETIC ENT PROCEDURE 13
        4.3.2 EMERGING ECONOMIES 13
       4.3.3 GOVERNMENT SUPPORT TO ENHANCE HEALTHCARE SERVICES 13


5. INDUSTRY ANALYSIS – PORTER’S 14


     5.1. THREAT OF NEW ENTRIES 14
     5.2. BUYER POWER 14
     5.3. THREAT OF SUBSTITUTION 14
    5.4. SUPPLIER POWER 14


6. GLOBAL ENT INDUSTRY– PESTEL ANALYSIS 14


7. GLOBAL ENT MARKET BY DEVICES 2012 & 2022 ($ BILLION) 14


    7.1. GLOBAL HEARING AID DEVICES MARKET 2012-2022 ($ BILLION) 14
        7.1.1 GLOBAL BEHIND-THE-EAR-AIDS MARKET 2012 & 2022 ($ BILLION) 14
        7.1.2 GLOBAL IN-THE-EAR AIDS MARKET 2012-2022 ($ BILLION) 14
        7.1.3 GLOBAL RECEIVER-IN-THE-EAR MARKET 2012-2022 ($ BILLION) 14
        7.1.4 GLOBAL CANAL HEARING AIDS MARKET 2012-2022 ($ BILLION) 14
    7.2. GLOBAL HEARING IMPLANTS MARKET 2012-2022 ($ BILLION) 14
        7.2.1 GLOBAL AUDITORY BRAINSTEM IMPLANTS MARKET 2012-2022 ($ BILLION) 14
        7.2.2 GLOBAL COCHLEAR IMPLANTS MARKET 2012-2022 ($ BILLION) 14
        7.2.3 GLOBAL MIDDLE EAR IMPLANTS MARKET 2012-2022 ($ BILLION) 14
        7.2.4 GLOBAL BONE ANCHORED HEARING SYSTEM MARKET 2012-2022 ($ BILLION) 14
    7.3. GLOBAL DIAGNOSTIC DEVICES MARKET 2012-2022 ($ BILLION) 14
        7.3.1 GLOBAL RIGID ENDOSCOPES MARKET 2012-2022 ($ BILLION) 14
        7.3.2 GLOBAL FLEXIBLE ENDOSCOPE MARKET 2012-2022 ($ BILLION) 14
        7.3.3 GLOBAL ROBOT ASSISTED ENDOSCOPE MARKET 2012-2022 ($ BILLION) 14
        7.3.4 GLOBAL HEARING SCREENING DEVICES MARKET 2012-2022 ($ BILLION) 14
    7.4. GLOBAL NASAL SPLINTS MARKET 2012-2022 ($ BILLION) 15
        7.4.1 GLOBAL INTERNAL NASAL SPLINTS MARKET 2012-2022 ($ BILLION) 15
       7.4.2 GLOBAL EXTERNAL NASAL SPLINTS MARKET 2012-2022 ($ BILLION) 15
    7.5. GLOBAL VOICE PROSTHESIS MARKET 2012-2022 ($ BILLION) 15
    7.6. GLOBAL SURGICAL DEVICES MARKET 2012-2022 ($ BILLION) 15
        7.6.1 GLOBAL RADIOFREQUENCY HAND PIECES MARKET 2012-2022 ($ BILLION) 15
        7.6.2 GLOBAL POWERED SURGICAL INSTRUMENT MARKET 2012-2022 ($ BILLION) 15
        7.6.3 GLOBAL OTOLOGICAL DRILL BURRS MARKET 2012-2022 ($ BILLION) 15
        7.6.4 GLOBAL ENT HAND INSTRUMENTS MARKET 2012-2022 ($ BILLION) 15
        7.6.5 GLOBAL TYMPANOSTOMY TUBES MARKET 2012-2022 ($ BILLION) 15
        7.6.6 GLOBAL SINUS DILATION DEVICES MARKET 2012-2022 ($ BILLION) 15
        7.6.7 GLOBAL NASAL PACKING DEVICES MARKET 2012-2022 ($ BILLION) 15


8. GLOBAL ENT INDUSTRY MARKET BY END USER APPLICATION 2012 & 2022($ BILLION) 16


    8.1. GLOBAL HOME USE MARKET 2012-2022 ($ BILLION) 16
    8.2. GLOBAL HOSPITALS MARKET 2012-2022 ($ BILLION) 16
    8.3. GLOBAL AMBULATORY SETTINGS MARKET 2012-2022 ($ BILLION) 16
    8.4. GLOBAL ENT CLINICS MARKET 2012-2022 ($ BILLION) 16


9. GLOBAL ENT INDUSTRY REGIONAL OUTLOOK 2014-2022 ($ BILLION) 16


    9.1. GLOBAL ENT MARKET VOLUME SHARE BY REGION 2012-2022 ($ BILLION) 16
    9.2. NORTH AMERICA 16
      9.2.1 NORTH AMERICA ENT MARKET ESTIMATES AND FORECAST 2012 – 2022 ($ BILLION) 16
        9.2.2 NORTH AMERICA ENT MARKET ESTIMATES AND FORECAST BY REGION 2012 – 2022 ($ BILLION) 16
          9.2.3 NORTH AMERICA ENT MARKET ESTIMATES AND FORECAST BY APPLICATION 2012 – 2022 ($ BILLION) 16
      9.2.3.1 US 16
          9.2.2.1.1. US ENT MARKET ESTIMATES AND FORECAST 2012 – 2022 ($ BILLION) 16
            9.2.2.1.2. US ENT MARKET ESTIMATES AND FORECAST BY APPLICATION 2012 – 2022 ($ BILLION) 16
       9.2.3.2 CANADA 16
        9.2.3.1.1. CANADA ENT MARKET ESTIMATES AND FORECAST 2012 – 2022 ($ BILLION) 16
       9.2.3.1.2. CANADA ENT MARKET ESTIMATES AND FORECAST BY APPLICATION 2012 – 2022 ($ BILLION) 16
     9.2.3.3 MEXICO 16
          9.2.3.3.1. MEXICO ENT MARKET ESTIMATES AND FORECAST 2012 – 2022 ($ BILLION) 16
          9.2.3.3.2. CANADA ENT MARKET ESTIMATES AND FORECAST BY APPLICATION 2012 – 2022 ($ BILLION) 16
        9.2.3.4 EUROPE 17
         9.2.3.4.1. EUROPE ENT MARKET ESTIMATES AND FORECAST 2012 – 2022 ($ BILLION) 17
         9.2.3.4.2. EUROPE ENT MARKET ESTIMATES AND FORECAST BY REGION 2012 – 2022 ($ BILLION) 17
         9.2.3.4.3. EUROPE ENT MARKET ESTIMATES AND FORECAST BY APPLICATION 2012 – 2022 ($ BILLION) 17
       9.2.3.5 GERMANY 17
          9.2.3.5.1. GERMANY ENT MARKET ESTIMATES AND FORECAST 2012 – 2022 ($ BILLION) 17
              9.2.3.5.2. GERMANY ENT MARKET ESTIMATES AND FORECAST BY APPLICATION 2012 – 2022 ($ BILLION) 17
           9.2.3.6 UK 17
           9.2.3.6.1. UK ENT MARKET ESTIMATES AND FORECAST 2012 – 2022 ($ BILLION) 17
          9.2.3.6.2. UK ENT MARKET ESTIMATES AND FORECAST BY APPLICATION 2012 – 2022 ($ BILLION) 17
        9.2.3.7 RUSSIA 17
          9.2.3.7.1. RUSSIA ENT MARKET ESTIMATES AND FORECAST 2012 – 2022 ($ BILLION) 17
          9.2.3.7.2. RUSSIA ENT MARKET ESTIMATES AND FORECAST BY APPLICATION 2012 – 2022 ($ BILLION) 17
    9.3. ASIA PACIFIC 17
        9.3.1 ASIA PACIFIC ENT MARKET ESTIMATES AND FORECAST 2012 – 2022 ($ BILLION) 17
        9.3.2 ASIA PACIFIC ENT MARKET ESTIMATES AND FORECAST BY REGION 2012 – 2022 ($ BILLION) 17
     9.3.3 ASIA PACIFIC ENT MARKET ESTIMATES AND FORECAST BY APPLICATION 2012 – 2022 ($ BILLION) 17
       9.3.3.1 CHINA 18
           9.3.3.1.1. CHINA ENT MARKET ESTIMATES AND FORECAST 2012 – 2022 ($ BILLION) 18
         9.3.3.1.2. CHINA ENT MARKET ESTIMATES AND FORECAST BY APPLICATION 2012 – 2022 ($ BILLION) 18
        9.3.3.2 INDIA 19
        9.3.4.2.1. INDIA ENT MARKET ESTIMATES AND FORECAST 2012 – 2022 ($ BILLION) 19
        9.3.4.2.2. INDIA ENT MARKET ESTIMATES AND FORECAST BY APPLICATION 2012 – 2022 ($ BILLION) 19
         9.3.3.3 SOUTH KOREA 19
     9.3.4.3.1. SOUTH KOREA ENT MARKET ESTIMATES AND FORECAST 2012 – 2022 ($ BILLION) 19
       9.3.4.3.2. SOUTH KOREA ENT MARKET ESTIMATES AND FORECAST BY APPLICATION 2012 – 2022 ($ BILLION) 19
    9.4. MIDDLE EAST & AFRICA 19
        9.4.1 MIDDLE EAST & AFRICA ENT MARKET ESTIMATES AND FORECAST 2012 – 2022 ($ BILLION) 19
        9.4.2 MIDDLE EAST & AFRICA ENT MARKET ESTIMATES AND FORECAST BY APPLICATION 2012 – 2022 ($ BILLION) 19
    9.5. CENTRAL & SOUTH AMERICA 19
        9.5.1 CENTRAL & SOUTH AMERICA ENT MARKET ESTIMATES AND FORECAST 2012 – 2022 ($ BILLION) 19
     9.5.2 CENTRAL & SOUTH AMERICA ENT MARKET ESTIMATES AND FORECAST BY APPLICATION 2012 – 2022 ($ BILLION) 19
               9.5.2.1 BRAZIL 19
              9.5.2.1.1. BRAZIL ENT MARKET ESTIMATES AND FORECAST 2012 – 2022 ($ BILLION) 19
                  9.5.2.1.2. BRAZIL ENT MARKET ESTIMATES AND FORECAST BY APPLICATION 2012 – 2022 ($ BILLION) 19


10. COMPETITIVE LANDSCAPE 19


    10.1. KARL STORZ GMBH & CO. KG 19
        10.1.1 COMPANY OVERVIEW 19
        10.1.2 FINANCIAL PERFORMANCE 19
        10.1.3 PRODUCT BENCHMARKING 19
        10.1.4 STRATEGIC INITIATIVES 19
    10.2. MEDTRONIC PLC 19
        10.2.1 COMPANY OVERVIEW 19
        10.2.2 FINANCIAL PERFORMANCE 19
        10.2.3 PRODUCT BENCHMARKING 20
        10.2.4 STRATEGIC INITIATIVES 20
    10.3. STRYKER CORPORATION 20
        10.3.1 COMPANY OVERVIEW 20
        10.3.2 FINANCIAL PERFORMANCE 20
        10.3.3 PRODUCT BENCHMARKING 20
        10.3.4 STRATEGIC INITIATIVES 20
    10.4. SMITH & NEPHEW PLC 20
        10.4.1 COMPANY OVERVIEW 20
        10.4.2 FINANCIAL PERFORMANCE 20
        10.4.3 PRODUCT BENCHMARKING 20
        10.4.4 STRATEGIC INITIATIVES 20
    10.5. OLYMPUS CORPORATION 20
        10.5.1 COMPANY OVERVIEW 20
        10.5.2 FINANCIAL PERFORMANCE 20
        10.5.3 PRODUCT BENCHMARKING 20
        10.5.4 STRATEGIC INITIATIVES 20
    10.6. ACCLARENT INC. (A SUBSIDIARY OF JOHNSON & JOHNSON) 20
        10.5.5 COMPANY OVERVIEW 20
        10.6.1 FINANCIAL PERFORMANCE 20
        10.6.2 PRODUCT BENCHMARKING 20
        10.6.3 STRATEGIC INITIATIVES 20
    10.7. COCHLEAR LIMITED 20
        10.7.1 COMPANY OVERVIEW 20
        10.7.2 FINANCIAL PERFORMANCE 20
        10.7.3 PRODUCT BENCHMARKING 20
        10.7.4 STRATEGIC INITIATIVES 20
    10.8. HOYA CORPORATION 20
        10.8.1 COMPANY OVERVIEW 20
        10.8.2 FINANCIAL PERFORMANCE 20
        10.8.3 PRODUCT BENCHMARKING 20
        10.8.4 STRATEGIC INITIATIVES 20
    10.9. SONOVA HOLDING AG 20
        10.9.1 COMPANY OVERVIEW 20
        10.9.2 FINANCIAL PERFORMANCE 20
        10.9.3 PRODUCT BENCHMARKING 20
        10.9.4 STRATEGIC INITIATIVES 21
    10.10. WILLIAM DEMANT HOLDING 21
        10.10.1 COMPANY OVERVIEW 21
        10.10.2 FINANCIAL PERFORMANCE 21
        10.10.3 PRODUCT BENCHMARKING 21
        10.10.4 STRATEGIC INITIATIVES 21
    10.11. ZOUNDS 21
        10.11.1 COMPANY OVERVIEW 21
        10.11.2 FINANCIAL PERFORMANCE 21
        10.11.3 PRODUCT BENCHMARKING 21
        10.11.4 STRATEGIC INITIATIVES 21
    10.12. AMERICAN HEARING SYSTEMS 21
        10.12.1 COMPANY OVERVIEW 21
        10.12.2 FINANCIAL PERFORMANCE 21
        10.12.3 PRODUCT BENCHMARKING 21
        10.12.4 STRATEGIC INITIATIVES 21
    10.13. REXTON 21
       10.13.1 COMPANY OVERVIEW 21
       10.13.2 FINANCIAL PERFORMANCE 21
       10.13.3 PRODUCT BENCHMARKING 21
       10.13.4 STRATEGIC INITIATIVES 21
    10.14. BELTONE 21
        10.14.1 COMPANY OVERVIEW 21
        10.14.2 FINANCIAL PERFORMANCE 21
        10.14.3 PRODUCT BENCHMARKING 21
        10.14.4 STRATEGIC INITIATIVES 21
    10.15. GN RESOUND A/S 21
        10.15.1 COMPANY OVERVIEW 21
        10.15.2 FINANCIAL PERFORMANCE 21
        10.15.3 PRODUCT BENCHMARKING 21
        10.15.4 STRATEGIC INITIATIVES 21
    10.16. SONIC INNOVATIONS 21
        10.16.1 COMPANY OVERVIEW 21
        10.16.2 FINANCIAL PERFORMANCE 21
        10.16.3 PRODUCT BENCHMARKING 21
        10.16.4 STRATEGIC INITIATIVES 21
    10.17. KATECHO 22
        10.17.1 COMPANY OVERVIEW 22
        10.17.2 FINANCIAL PERFORMANCE 22
        10.17.3 PRODUCT BENCHMARKING 22
        10.17.4 STRATEGIC INITIATIVES 22
    10.18. AVENTAMED 22
        10.18.1 COMPANY OVERVIEW 22
        10.18.2 FINANCIAL PERFORMANCE 22
        10.18.3 PRODUCT BENCHMARKING 22
        10.18.4 STRATEGIC INITIATIVES 22
    10.19. EPIC SYSTEMS CORPORATION 22
        10.19.1 COMPANY OVERVIEW 22
        10.19.2 FINANCIAL PERFORMANCE 22
        10.19.3 PRODUCT BENCHMARKING 22
        10.19.4 STRATEGIC INITIATIVES 22

TABLE # 1 GLOBAL ENT MARKET BY HEARING AID DEVICES 2012-2022 ($ BILLION) 22
TABLE # 2 GLOBAL BEHIND-THE-EAR-AIDS MARKET 2012-2022 ($ BILLION) 22
TABLE # 3 GLOBAL IN-THE-EAR AIDS MARKET 2012-2022 ($ BILLION) 22
TABLE # 4 GLOBAL RECEIVER-IN-THE-EAR MARKET 2012-2022 ($ BILLION) 22
TABLE # 5 GLOBAL CANAL HEARING AIDS MARKET 2012-2022 ($ BILLION) 22
TABLE # 6 GLOBAL ENT MARKET BY HEARING IMPLANTS 2012-2022 ($ BILLION) 22
TABLE # 7 GLOBAL COCHLEAR IMPLANTS MARKET 2012-2022 ($ BILLION) 22
TABLE # 8 GLOBAL MIDDLE EAR IMPLANTS MARKET 2012-2022 ($ BILLION) 22
TABLE # 9 GLOBAL BONE ANCHORED HEARING SYSTEM MARKET 2012-2022 ($ BILLION) 22
TABLE # 10 GLOBAL ENT MARKET BY DIAGNOSTIC DEVICES 2012-2022 ($ BILLION) 23
TABLE # 11 GLOBAL RIGID ENDOSCOPES MARKET 2012-2022 ($ BILLION) 23
TABLE # 12 GLOBAL FLEXIBLE ENDOSCOPE MARKET 2012-2022 ($ BILLION) 23
TABLE # 13 GLOBAL ROBOT ASSISTED ENDOSCOPE MARKET 2012-2022 ($ BILLION) 23
TABLE # 14 GLOBAL HEARING SCREENING DEVICES MARKET 2012-2022 ($ BILLION) 23
TABLE # 15 GLOBAL ENT MARKET BY NASAL SPLINTS 2012-2022 ($ BILLION) 23
TABLE # 16 GLOBAL INTERNAL NASAL SPLINTS MARKET 2012-2022 ($ BILLION) 23
TABLE # 17 GLOBAL EXTERNAL NASAL SPLINTS MARKET 2012-2022 ($ BILLION) 23
TABLE # 18 GLOBAL ENT MARKET BY VOICE PROSTHESIS 2012-2022 ($ BILLION) 23
TABLE # 19 GLOBAL ENT MARKET BY SURGICAL DEVICES 2012-2022 ($ BILLION) 23
TABLE # 20 GLOBAL RADIOFREQUENCY HAND PIECES MARKET 2012-2022 ($ BILLION) 23
TABLE # 21 GLOBAL POWERED SURGICAL INSTRUMENT MARKET 2012-2022 ($ BILLION) 23
TABLE # 22 GLOBAL OTOLOGICAL DRILL BURRS MARKET 2012-2022 ($ BILLION) 23
TABLE # 23 GLOBAL ENT HAND INSTRUMENTS MARKET 2012-2022 ($ BILLION) 23
TABLE # 24 GLOBAL TYMPANOSTOMY TUBES MARKET 2012-2022 ($ BILLION) 23
TABLE # 25 GLOBAL SINUS DILATION DEVICES MARKET 2012-2022 ($ BILLION) 23
TABLE # 26 GLOBAL NASAL PACKING DEVICES MARKET 2012-2022 ($ BILLION) 23
TABLE # 27 GLOBAL ENT INDUSTRY MARKET BY END USER APPLICATION 2012-2022 ($ BILLION) 24
TABLE # 28 GLOBAL HOME USE MARKET BY END USER APPLICATION 2012-2022 ($ BILLION) 24
TABLE # 29 GLOBAL HOSPITALS MARKET BY END USER APPLICATION 2012-2022 ($ BILLION) 24
TABLE # 30 GLOBAL AMBULATORY SETTINGS MARKET BY END USER APPLICATION 2012-2022 ($ BILLION) 24
TABLE # 31 GLOBAL ENT CLINICS MARKET BY END USER APPLICATION 2012-2022 ($ BILLION) 24
TABLE # 32 GLOBAL ENT INDUSTRY REGIONAL OUTLOOK 2012-2022 (IN $ BILLION) 24
TABLE # 33 NORTH AMERICA ENT MARKET ESTIMATES AND FORECAST 2012 – 2022 ($ BILLION) 24
TABLE # 34 NORTH AMERICA ENT MARKET ESTIMATES AND FORECAST BY REGION 2012 – 2022 ($ BILLION) 24
TABLE # 35 NORTH AMERICA ENT MARKET ESTIMATES AND FORECAST BY APPLICATION 2012 – 2022 ($ BILLION) 24
TABLE # 36 EUROPE MARKET ENT ESTIMATES AND FORECAST 2012 – 2022 ($ BILLION) 24
TABLE # 37 EUROPE MARKET ENT ESTIMATES AND FORECAST BY REGION 2012 – 2022 ($ BILLION) 24
TABLE # 38 EUROPE MARKET ENT ESTIMATES AND FORECAST BY APPLICATION 2012 – 2022 ($ BILLION) 24
TABLE # 39 ASIA PACIFIC MARKET ENT ESTIMATES AND FORECAST 2012 – 2022 ($ BILLION) 24
TABLE # 40 ASIA PACIFIC MARKET ENT ESTIMATES AND FORECAST BY REGION 2012 – 2022 ($ BILLION) 24
TABLE # 41 ASIA PACIFIC MARKET ENT ESTIMATES AND FORECAST BY APPLICATION 2012 – 2022 ($ BILLION) 24
TABLE # 42 MIDDLE EAST & AFRICA ENT MARKET ESTIMATES AND FORECAST 2012 – 2022 ($ BILLION) 24
TABLE # 43 MIDDLE EAST & AFRICA ENT MARKET ESTIMATES AND FORECAST BY APPLICATION 2012 – 2022 ($ BILLION) 24

FIGURE # 1 GLOBAL ENT MARKET SHARE 2012-2022 ($ BILLION) 25
FIGURE # 2 MARKET SHARE BY REGIONS 25
FIGURE # 3 UNITED STATES ENT MARKET ESTIMATES AND FORECAST 2012 – 2022 ($ BILLION) 25
FIGURE # 4 CANADA ENT MARKET ESTIMATES AND FORECAST 2012 – 2022 ($ BILLION) 25
FIGURE # 5 MEXICO ENT MARKET ESTIMATES AND FORECAST 2012 – 2022 ($ BILLION) 25
FIGURE # 6 UK ENT MARKET ESTIMATES AND FORECAST 2012 – 2022 ($ BILLION) 25
FIGURE # 7 FRANCE ENT MARKET ESTIMATES AND FORECAST 2012 – 2022 ($ BILLION) 25
FIGURE # 8 GERMANY ENT MARKET ESTIMATES AND FORECAST 2012 – 2022 ($ BILLION) 25
FIGURE # 9 APAC ENT MARKET ESTIMATES AND FORECAST 2012 – 2022 ($ BILLION) 25
FIGURE # 10 CHINA ENT MARKET ESTIMATES AND FORECAST 2012 – 2022 ($ BILLION) 25
FIGURE # 11 INDIA ENT MARKET ESTIMATES AND FORECAST 2012 – 2022 ($ BILLION) 25
FIGURE # 12 MIDDLE EAST & AFRICA ENT MARKET ESTIMATES AND FORECAST 2012 – 2022 ($ BILLION) 25
FIGURE # 13 CENTRAL & SOUTH AMERICA ENT MARKET ESTIMATES AND FORECAST 2012 – 2022 ($ BILLION) 25
FIGURE # 14 BRAZIL ENT MARKET ESTIMATES AND FORECAST 2012 – 2022 ($ BILLION) 25

Choose License


Contact Information

: 24/7 Research Support

: sales@briskinsights.com

: +448081890034 (UK)